Home › Major Depressive Disorder › Nevada
Major Depressive Disorder clinical trials in Nevada
13 studies for Major Depressive Disorder are looking for participants at sites in Nevada.
Cities in Nevada
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Vector Clinical Trials, Las Vegas
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Oct 1, 2026 · NCT07573176A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Redbird Research, Las Vegas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07621237A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Redbird Research, LLC, Las Vegas
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Las Vegas
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT06830044ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Redbird Research LLC, Las Vegas
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07284667A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Las Vegas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 26, 2026 · NCT07300969A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Redbird Research, Las Vegas
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 10, 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Vector Clinical Trials, Las Vegas
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 6, 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- IMA Clinical Research Las Vegas, Las Vegas
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 3, 2026 · NCT06775379Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Las Vegas
- Clinical Research Site, Las Vegas
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Redbird Research /ID# 277485, Las Vegas
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 15, 2026 · NCT07276997Study of ALTO-300 in MDD
- Site 344, Las Vegas
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 24, 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Las Vegas
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Jan 23, 2025 · NCT06223880From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.